New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
The proposal seeks to move any future LDT authority away from the FDA
From – National Intelligence Report
Despite ongoing efforts to delay the changes to the Clinical Laboratory Fee Schedule (CLFS) directed by the Protecting Access to Medicare Act of 2014 (PAMA), the Centers for Medicare & Medicaid Services’s final rule implementing the…
From – National Intelligence Report
Despite the looming challenges of a proposed overhaul of the Medicare payment system for clinical laboratory services and…